0001209191-20-046470.txt : 20200812
0001209191-20-046470.hdr.sgml : 20200812
20200812191706
ACCESSION NUMBER: 0001209191-20-046470
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200810
FILED AS OF DATE: 20200812
DATE AS OF CHANGE: 20200812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WHIMS JAMES L
CENTRAL INDEX KEY: 0001216815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49602
FILM NUMBER: 201096640
MAIL ADDRESS:
STREET 1: C/O SYNAPTICS INCORPORATED
STREET 2: 1251 MCKAY DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNAPTICS Inc
CENTRAL INDEX KEY: 0000817720
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 770118518
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0627
BUSINESS ADDRESS:
STREET 1: 1251 MCKAY DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95131-3326
BUSINESS PHONE: 408-904-1100
MAIL ADDRESS:
STREET 1: 1251 MCKAY DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95131-3326
FORMER COMPANY:
FORMER CONFORMED NAME: SYNAPTICS INC
DATE OF NAME CHANGE: 20010216
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-10
0
0000817720
SYNAPTICS Inc
SYNA
0001216815
WHIMS JAMES L
14573 BIG BASIN WAY
SARATOGA
CA
95070
1
0
0
0
Common Stock
2020-08-10
4
M
0
4500
46.50
A
31262
D
Common Stock
2020-08-10
4
S
0
3106
85.4196
D
28156
D
Common Stock
2020-08-10
4
S
0
1031
86.1608
D
27125
D
Common Stock
2020-08-10
4
S
0
250
87.88
D
26875
D
Common Stock
2020-08-10
4
S
0
113
88.99
D
26762
D
Director Stock Option (Right to Buy)
46.50
2020-08-10
4
M
0
4500
0.00
D
2020-10-28
Common Stock
4500
0
D
The shares were sold pursuant to a 10b5-1 Trading Plan dated June 2, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.78, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.82 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.65 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant, until fully vested on October 28, 2014.
/s/ Kermit Nolan, as attorney-in-fact
2020-08-12